Add Company
Join Now

ARMGO Pharma Revenue and Competitors

License our Company Data API

Ardsley, NY

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ARMGO Pharma's estimated annual revenue is currently $852.5k per year.(i)
  • ARMGO Pharma's estimated revenue per employee is $77,500

Employee Data

  • ARMGO Pharma has 11 Employees.(i)
  • ARMGO Pharma grew their employee count by 0% last year.

ARMGO Pharma's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Operating Officer, General CounselReveal Email/Phone
5
VP, Business DevelopmentReveal Email/Phone
6
Executive ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M30%N/AN/A
#2
N/A2043%N/AN/A
#3
$6.7M33-6%N/AN/A
#4
$34.4M222-1%N/AN/A
#5
$5.2M670%$10MN/A
#6
$2M130%N/AN/A
#7
$7.5M370%$51.6MN/A
#8
$0.3M1-50%N/AN/A
#9
$4.3M21-16%$3.3MN/A
#10
$3.6M205%N/AN/A
Add Company

What Is ARMGO Pharma?

ARMGO Pharma Inc., is a privately held biopharmaceutical company dedicated to applying original, targeted science to the discovery and development of novel small-molecule therapeutics to treat debilitating cardiac, musculoskeletal, and neurological disorders. The company's proprietary drugs, known as Rycals®, are a new class of oral agents that repair calcium leaks through the Ryanodine Receptor (RyR). ARMGO Pharma has been awarded an exclusive, worldwide license from Columbia University for its RyR technology based on the research of founding scientist Andrew R. Marks, M.D.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$852.5k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A12-29%N/A
#2
$5.8M23-8%N/A
#3
$9.5M4224%N/A
#4
$14.2M719%N/A
#5
$20.5M962%N/A